Details of the Drug Formulations

General Information of Drug (ID: DMBMUWZ)

Drug Name
Emtricitabine Drug Info
Synonyms
Coviracil; DOTFC; Emtriva; RCV; Racivir; BW 1592; BW 524W91; BW524W91; BW-524W91; Coviracil (TN); Coviracil(TM); DRG-0208; Emtriva(TM); Emtricitabine (JAN/USAN/INN); Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine; Beta-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine; (-)-.beta.-L-FTC; (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine; (-)-2'-Deoxy-5-fluoro-3'-thiacytidine; (-)-FTC; (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine; (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone; 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine; 2',3',5-FTC; 2',3'-Dideoxy-5-fluoro-3'-thiacytidine; 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine; 2'-Deoxy-5-fluoro-3'-thiacytidine; 2-FTC; 3'-Thia-2'.3'-dideoxy-5-fluorocytidine; 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one; 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one; 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine; 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine; 524W91; FTC
Indication
Disease Entry ICD 11 Status REF
Hepatitis virus infection 1E50-1E51 Approved [1]
Human immunodeficiency virus infection 1C62 Approved [1]
Hepatitis B virus infection 1E51.0 Phase 3 [2]
Therapeutic Class
Anti-HIV Agents
Cross-matching ID
PubChem CID
60877
ChEBI ID
CHEBI:31536
CAS Number
143491-57-0
TTD ID
D0S9SD
VARIDT ID
DR00672
ACDINA ID
D00228

Full List of Drug Formulations Containing This Drug

Emtricitabine 200 mg capsule
Company Formulation ID FDA Description
Physicians Total Care F07209 Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Water; Crospovidone; Povidone; Cellulose, microcrystalline; Gelatin
RemedyRepack F07208 Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Water; Crospovidone; Cellulose, microcrystalline; Gelatin; Povidones
Gilead Sciences F07207 Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Water; Crospovidone (15 mpa.s at 5%); Gelatin, unspecified; Microcrystalline cellulose; Povidone, unspecified
------------------------------------------------------------------------------------

References

1 Nat Rev Drug Discov. 2013 Feb;12(2):87-90.
2 Clinical pipeline report, company report or official report of Gilead (2011).